Adjuvant Chemotherapy with Doxorubicin-Containing Regimen for 326 Stage II Breast Cancers: 15-Year Results
Fractionated Stereotactic Radiotherapy with cis-Platinum Radiosensitization in the Treatment of Recurrent, Progressive, or Persistent Malignant Astrocytoma
Paclitaxel as Salvage Therapy in Advanced Pretreated Ovarian Cancer: A Phase II Study
Paclitaxel as a Radiosensitizer Combined with Fractionated Stereotactic Radiotherapy in the Treatment of Recurrent Medulloblastoma
Effect of Angiotensin II on Arteriovenous Shunting Assessed by Hepatic Arterial Perfusion Scintigraphy
A Phase II Study of 5-Fluorouracil, Leucovorin, Adriamycin, and Cisplatin (FLAP) for Metastatic Gastric and Gastroesophageal Junction Adenocarcinoma
Tumor Markers in the Diagnosis of Malignant Serous Effusions
A Phase II Trial of Edatrexate in Patients with Advanced Renal Cell Carcinoma
High Dose Rate Vaginal Brachytherapy in Early Stage Endometrial Carcinoma: Preliminary Analysis
Phase I Dose Intensification Study of 2-Weekly Epirubicin with GM-CSF in Advanced Cancer
Effect of Brain Irradiation on Blood-CSF Barrier Permeability of Chemotherapeutic Agents
Standard-Dose Recombinant Human Granulocyte Colony-Stimulating Factor (rhG-CSF) Allows Safe and Repeated Administration of High-Dose Cyclophosphamide, Etoposide, and Cisplatin (CEP)
Primary Non-Hodgkin's Lymphoma of the Maxillary Sinus
Cisplatin, Mitomycin, and Vindesine Followed by Intraoperative and Postoperative Radiotherapy for Stage III Non-Small Cell Lung Cancer: Final Results of a Phase II study
Mitomycin Lung Toxicity
Pretreatment Characteristics of Carcinoid Tumors of the Lung Which Predict Aggressive Behavior
A Prospective Phase II Trial to Evaluate the Efficacy and Toxicity of Hepatic Arterial Infusion of Ifosfamide in Patients with Inoperable Localized Hepatocellular Carcinoma
Treatment of Superior and Inferior Vena Cava Syndromes of Malignant Cause with Wallstent Catheter Placed Percutaneously
A Phase II Study of Topotecan in Patients with Recurrent Head and Neck Cancer
Activity of Combination Chemotherapy in Brain Metastases from Breast and Lung Adenocarcinoma
Megestrol Acetate in the Treatment of Hormone Refractory Prostate Cancer
Evaluation of Long-Term Daily Administration of Oral Low-Dose Etoposide in Elderly Patients with Relapsing or Refractory Non-Hodgkin's Lymphoma
The Addition of Bleomycin and Dose-Escalated Ifosfamide to the Combination of Cisplatin Plus Ifosfamide Does Not Improve Survival in Advanced or Recurrent Cervical Carcinoma
A Phase II Trial of Cisplatin and Interferon Alpha 2b in Patients with Advanced Bladder Cancer
Rheumatic Symptoms Following Adjuvant Therapy for Breast Cancer